Mechanism of Action
Membrane Disruption at Low Charge
Unlike magainins (+4 charge), most temporins have low positive charge (+1 to +3) yet are antimicrobial. They compensate with high hydrophobicity and a compact helix that inserts efficiently into bacterial membranes. The mechanism is primarily carpet-like membrane disruption rather than discrete pore formation. Temporin-L (the most active family member) has +3 charge and strong hydrophobicity, giving activity against Gram-negative bacteria as well.
Synergistic Combinations
Individual temporins often show narrow-spectrum activity (primarily Gram-positive). However, combinations of temporin-A and temporin-B show synergistic activity against Gram-negative bacteria. This synergy arises from sequential membrane destabilization: temporin-B disrupts the outer membrane, allowing temporin-A access to the inner membrane. Temporin combinations thus broaden the spectrum beyond individual members.
Research Summary
Activity Against Biofilms
PreclinicalTemporin-A is notable for activity against Staphylococcus epidermidis biofilms at concentrations similar to its planktonic MIC, unlike many antibiotics with poor biofilm penetration. In mouse catheter-associated biofilm models, temporin-A coating reduces biofilm colonization. These properties are relevant for medical device coatings and wound dressings.
Antifungal and Antiparasitic Activity
PreclinicalSeveral temporin variants show activity against Candida spp. and Leishmania parasites. Temporin-A and temporin-B disrupt Candida albicans biofilms and planktonic cells. Anti-Leishmania activity involves disruption of the parasite plasma membrane and mitochondrial membrane potential, with selectivity over mammalian cells.
Structural Optimization
PreclinicalDue to their short length, temporins are attractive scaffolds for medicinal chemistry optimization. D-amino acid substitutions, C-terminal amidation (already present in natural forms), and hybrid peptides with other AMP sequences have been explored to improve spectrum, stability, and selectivity. Several temporin analogs show enhanced Gram-negative activity while maintaining low hemolytic toxicity.
Calculate your Temporin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Antibacterial MIC determination | 1-128 ug/mL | Single plate read | In vitro (broth microdilution) |
| Biofilm prevention (catheter coating) | 10-100 ug/mL coating concentration | Single application | Surface coating |
| Anti-Leishmania activity | 1-50 uM | Single time-point | In vitro (parasite suspension) |
All protocols are research context only. No clinical development for temporins as standalone antibiotics. Used primarily as AMP scaffold and mechanistic tool.
Interactions
Safety Profile
Temporins are hemolytic at concentrations above their antimicrobial range, particularly temporin-L which has high hemolytic activity. Temporin-A shows better selectivity with a therapeutic index (HC50/MIC) of ~10-50 for Staphylococcus. No human clinical data exists. Use is restricted to research and potential topical/local applications where systemic absorption is minimal. Not available as a human therapeutic.
References
- [1]Simmaco M, et al. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem. 1996;242(3):788-792.
- [2]Mangoni ML, et al. Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification. Biochim Biophys Acta. 2008;1778(12):2620-2627.
- [3]Di Grazia A, et al. D-amino acid analogues of temporin-L are highly efficient antimicrobial agents. Sci Rep. 2015;5:12518.